vs
Smurfit Westrock（SW）とTENET HEALTHCARE CORP（THC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Smurfit Westrockの直近四半期売上が大きい（$7.6B vs $5.5B、TENET HEALTHCARE CORPの約1.4倍）。TENET HEALTHCARE CORPの純利益率が高く（11.7% vs 1.3%、差は10.4%）。TENET HEALTHCARE CORPの前年同期比売上増加率が高い（9.0% vs 0.5%）。Smurfit Westrockの直近四半期フリーキャッシュフローが多い（$612.0M vs $367.0M）。過去8四半期でSmurfit Westrockの売上複合成長率が高い（60.8% vs 1.5%）
アイルランドのダブリンに本社を置くSmurfit Westrock plcは、段ボールや紙を原料とした包装資材の製造を主力事業としており、ニューヨーク証券取引所とロンドン証券取引所の両方に上場しています。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
SW vs THC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $7.6B | $5.5B |
| 純利益 | $97.0M | $644.0M |
| 粗利率 | 18.2% | — |
| 営業利益率 | 5.1% | 15.4% |
| 純利益率 | 1.3% | 11.7% |
| 売上前年比 | 0.5% | 9.0% |
| 純利益前年比 | -33.6% | 12.6% |
| EPS（希薄化後） | $0.18 | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $7.6B | $5.5B | ||
| Q3 25 | $8.0B | $5.3B | ||
| Q2 25 | $7.9B | $5.3B | ||
| Q1 25 | $7.7B | $5.2B | ||
| Q4 24 | $7.5B | $5.1B | ||
| Q3 24 | $7.7B | $5.1B | ||
| Q2 24 | $3.0B | $5.1B | ||
| Q1 24 | $2.9B | $5.4B |
| Q4 25 | $97.0M | $644.0M | ||
| Q3 25 | $246.0M | $579.0M | ||
| Q2 25 | $-28.0M | $522.0M | ||
| Q1 25 | $384.0M | $622.0M | ||
| Q4 24 | $146.0M | $572.0M | ||
| Q3 24 | $-150.0M | $681.0M | ||
| Q2 24 | $132.0M | $477.0M | ||
| Q1 24 | $191.0M | $2.3B |
| Q4 25 | 18.2% | — | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 20.6% | — | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 23.3% | — | ||
| Q1 24 | 24.2% | — |
| Q4 25 | 5.1% | 15.4% | ||
| Q3 25 | 6.6% | 16.8% | ||
| Q2 25 | 3.2% | 15.6% | ||
| Q1 25 | 7.2% | 18.1% | ||
| Q4 24 | 5.3% | 16.2% | ||
| Q3 24 | 0.7% | 21.3% | ||
| Q2 24 | 8.2% | 14.9% | ||
| Q1 24 | 10.5% | 61.2% |
| Q4 25 | 1.3% | 11.7% | ||
| Q3 25 | 3.1% | 10.9% | ||
| Q2 25 | -0.4% | 9.9% | ||
| Q1 25 | 5.0% | 11.9% | ||
| Q4 24 | 1.9% | 11.3% | ||
| Q3 24 | -2.0% | 13.3% | ||
| Q2 24 | 4.4% | 9.3% | ||
| Q1 24 | 6.5% | 43.5% |
| Q4 25 | $0.18 | $4.22 | ||
| Q3 25 | $0.47 | $3.86 | ||
| Q2 25 | $-0.05 | $3.14 | ||
| Q1 25 | $0.73 | $4.27 | ||
| Q4 24 | $-0.12 | $3.79 | ||
| Q3 24 | $-0.30 | $4.89 | ||
| Q2 24 | $0.51 | $2.64 | ||
| Q1 24 | $0.73 | $21.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $892.0M | $2.9B |
| 総負債低いほど良い | $13.4B | $13.1B |
| 株主資本純資産 | $18.3B | $4.2B |
| 総資産 | $45.2B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.73× | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $892.0M | $2.9B | ||
| Q3 25 | $851.0M | $3.0B | ||
| Q2 25 | $778.0M | $2.6B | ||
| Q1 25 | $797.0M | $3.0B | ||
| Q4 24 | $855.0M | $3.0B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | $26.8K | $2.9B | ||
| Q1 24 | $108 | $2.5B |
| Q4 25 | $13.4B | $13.1B | ||
| Q3 25 | $13.3B | $13.1B | ||
| Q2 25 | $13.3B | $13.1B | ||
| Q1 25 | $12.9B | $13.1B | ||
| Q4 24 | $12.5B | $13.1B | ||
| Q3 24 | $13.2B | $12.8B | ||
| Q2 24 | — | $12.8B | ||
| Q1 24 | — | $12.8B |
| Q4 25 | $18.3B | $4.2B | ||
| Q3 25 | $18.4B | $4.0B | ||
| Q2 25 | $18.3B | $3.7B | ||
| Q1 25 | $17.9B | $4.2B | ||
| Q4 24 | $17.4B | $4.2B | ||
| Q3 24 | $18.0B | $3.8B | ||
| Q2 24 | $14.5K | $3.5B | ||
| Q1 24 | $108 | $3.5B |
| Q4 25 | $45.2B | $29.7B | ||
| Q3 25 | $45.6B | $29.4B | ||
| Q2 25 | $45.7B | $28.7B | ||
| Q1 25 | $44.6B | $29.2B | ||
| Q4 24 | $43.8B | $28.9B | ||
| Q3 24 | $45.0B | $29.4B | ||
| Q2 24 | $26.8K | $29.3B | ||
| Q1 24 | $108 | $28.9B |
| Q4 25 | 0.73× | 3.10× | ||
| Q3 25 | 0.72× | 3.26× | ||
| Q2 25 | 0.73× | 3.49× | ||
| Q1 25 | 0.72× | 3.13× | ||
| Q4 24 | 0.72× | 3.14× | ||
| Q3 24 | 0.73× | 3.33× | ||
| Q2 24 | — | 3.67× | ||
| Q1 24 | — | 3.70× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $1.2B | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $612.0M | $367.0M |
| FCFマージンFCF / 売上 | 8.1% | 6.6% |
| 設備投資強度設備投資 / 売上 | 7.7% | 6.6% |
| キャッシュ転換率営業CF / 純利益 | 12.32× | 1.14× |
| 直近12ヶ月FCF直近4四半期 | $1.2B | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.2B | $731.0M | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $829.0M | $936.0M | ||
| Q1 25 | $235.0M | $815.0M | ||
| Q4 24 | $781.0M | $-331.0M | ||
| Q3 24 | $320.0M | $1.0B | ||
| Q2 24 | $340.0M | $747.0M | ||
| Q1 24 | $42.0M | $586.0M |
| Q4 25 | $612.0M | $367.0M | ||
| Q3 25 | $523.0M | $778.0M | ||
| Q2 25 | $307.0M | $743.0M | ||
| Q1 25 | $-242.0M | $642.0M | ||
| Q4 24 | $212.0M | $-661.0M | ||
| Q3 24 | $-192.0M | $829.0M | ||
| Q2 24 | $163.0M | $602.0M | ||
| Q1 24 | $-166.0M | $346.0M |
| Q4 25 | 8.1% | 6.6% | ||
| Q3 25 | 6.5% | 14.7% | ||
| Q2 25 | 3.9% | 14.1% | ||
| Q1 25 | -3.2% | 12.3% | ||
| Q4 24 | 2.8% | -13.0% | ||
| Q3 24 | -2.5% | 16.2% | ||
| Q2 24 | 5.5% | 11.8% | ||
| Q1 24 | -5.7% | 6.4% |
| Q4 25 | 7.7% | 6.6% | ||
| Q3 25 | 7.6% | 5.3% | ||
| Q2 25 | 6.6% | 3.7% | ||
| Q1 25 | 6.2% | 3.3% | ||
| Q4 24 | 7.5% | 6.5% | ||
| Q3 24 | 6.7% | 4.2% | ||
| Q2 24 | 6.0% | 2.8% | ||
| Q1 24 | 7.1% | 4.5% |
| Q4 25 | 12.32× | 1.14× | ||
| Q3 25 | 4.61× | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | 0.61× | 1.31× | ||
| Q4 24 | 5.35× | -0.58× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | 2.58× | 1.57× | ||
| Q1 24 | 0.22× | 0.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
SW
| Packaging | $3.3B | 43% |
| Other | $3.2B | 43% |
| Paper | $1.1B | 14% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
